Arkema Divests Phosphorus Derivatives Business
Arkema has announced the proposed divestment of Febex, a company specializing in phosphorus-based chemistry, to Belgian group Prayon.
Arkema has proposed the divestment of Febex, a global player in phosphorus derivatives (high purity phosphoric acid, sodium hypophosphite and derivatives), used primarily in electronics and in the pharmaceuticals industry. Part of the Performance Additives Business Line and with little integration within the Group’s other activities, Febex reported sales of around €30 million in 2021, employs 59 people, and operates 1 site in Switzerland.
Febex will join Prayon, an Belgian industrial group specializing in phosphorus-based chemistry.
The divestment is expected to be finalized in 1st quarter 2023, and is subject to information and prior consultation process with employee representative bodies in France and to approval by the relevant Swiss authorities.
Related Content
-
From Zero to Full: The Day That Nearly “Finished” a Finishing Shop
What began as doomsday for this Michigan finisher turned out to be a victory when the shop went from no ecoat business to full capacity. After that day and within two weeks, management onboarded 72 employees to keep up with its business.
-
An Altruistic Growth Strategy Puts People First
Professional Plating emphasizes investing in its team and fostering a supportive environment on the shop floor.
-
Take Action to Mitigate Cyber Threats Before It’s Too Late
Cybersecurity is increasingly becoming a concern for all companies. Stay alert and heed these pointers for avoiding data breaches and other network and online disruptions that can be detrimental to your shop.
